Last reviewed · How we verify
NCT05863208
Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision
NA trial testing Artificial intelligence in Adenoma Detection Rate in 1,000 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | E-DA Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 1,000 |
| Start date | 2 May 2023 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Artificial intelligence
- Endocuff vision
- High-definition endoscope
Conditions studied
- Adenoma Detection Rate — all drugs for Adenoma Detection Rate →
Sponsor
E-DA Hospital
Who can join
40 and older, any sex, with Adenoma Detection Rate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adenoma detection rate (ADR) is considered the single most important quality measure in colonoscopy and a higher ADR can reduce the risk of interval colorectal cancer (CRC). Several kinds of new endoscopes and accessories have been accessed to investigate the abilities of improving the ADR. Artificial intelligence (AI) and Endocuff vision are promising new devices to improve the ADR. However, the effect of combining AI and Endocuff vision on ADR remains unclear. The aim of this prospective randomized study is to compare the ADR of AI plus Endocuff vision, AI alone and standard colonoscopy examination.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05863208
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Artificial intelligence
Trials testing the same drug.
- NCT06268418 — Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy · completed
- NCT06667635 — Intelligent Analysis and Clinical Validation of Cerebral Small Vessel Disease on Magnetic Resonance Imaging：A Multi-cent · not yet recruiting
- NCT06942130 — The Application of Artificial Intelligence in Dental Education · NA · completed
- NCT05985057 — A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUs · completed
- NCT06051682 — Optimization of the Diagnosis of Bone Fractures in Patients Treated in the Emergency Department by Using Artificial Inte · NA · unknown
Other recruiting trials for Adenoma Detection Rate
Currently open trials in the same condition.
- NCT06961149 — Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate · NA · recruiting
- NCT06678477 — Comparison of the Performance Between Conventional Colonoscopy and 3D Colonoscopy in Positive Fecal Immunochemical Test · NA · recruiting
- NCT07076966 — Comparison of Adenoma Detection Rate in 3D vs. 2D Surveillance Colonoscopy · NA · recruiting
- NCT05125939 — Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study · recruiting
Other E-DA Hospital trials
Trials by the same sponsor.
- NCT03848260 — A Real-Time Magnetic Device Prototype for Temporary Management of Paralytic Lagophthalmos · NA · suspended
- NCT06482411 — Risk Factors Affect Weight Loss Outcomes After Treatment. · completed
- NCT06460402 — Ice Therapy and Warm Baths for Hemorrhoidectomy Wound Care · NA · enrolling by invitation
- NCT06420388 — 2% Lidocaine Gel in Reducing Postoperative Pain Following Haemorrhoidectomy · NA · recruiting
- NCT03812016 — A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05863208 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by E-DA Hospital
- Last refreshed: 27 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05863208.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing